Lemaire, B.; Frias, M.A.; Golaz, O.; Magnin, J.-L.; Viette, V.; Vuilleumier, N.; Waldvogel Abramowski, S.
Ferritin: A Biomarker Requiring Caution in Clinical Decision. Diagnostics 2024, 14, 386.
https://doi.org/10.3390/diagnostics14040386
AMA Style
Lemaire B, Frias MA, Golaz O, Magnin J-L, Viette V, Vuilleumier N, Waldvogel Abramowski S.
Ferritin: A Biomarker Requiring Caution in Clinical Decision. Diagnostics. 2024; 14(4):386.
https://doi.org/10.3390/diagnostics14040386
Chicago/Turabian Style
Lemaire, Baptiste, Miguel A. Frias, Olivier Golaz, Jean-Luc Magnin, Véronique Viette, Nicolas Vuilleumier, and Sophie Waldvogel Abramowski.
2024. "Ferritin: A Biomarker Requiring Caution in Clinical Decision" Diagnostics 14, no. 4: 386.
https://doi.org/10.3390/diagnostics14040386
APA Style
Lemaire, B., Frias, M. A., Golaz, O., Magnin, J. -L., Viette, V., Vuilleumier, N., & Waldvogel Abramowski, S.
(2024). Ferritin: A Biomarker Requiring Caution in Clinical Decision. Diagnostics, 14(4), 386.
https://doi.org/10.3390/diagnostics14040386